Qualifying manufacturers will be able to submit some data while clinical trials are ongoing. Marty Makary is the commissioner ...

Califf completed his second term as FDA commissioner in January with the change in administrations. He’s only the second ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

An FDA pilot program, known as the Commissioner’s Priority Voucher program, could drastically change the way pharmaceutical ...

A new pilot program announced by FDA Commissioner Martin Makary would award vouchers that could cut drug reviews to one or ...

Food and Drug Administration Commissioner Marty Makary holds up a study during a press conference at the Department of Health and Human Services in Washington, D.C., April 22, 2025.

June 4 (UPI) --Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after a recent study raised concerns about medical side effects.

The Chronicle spoke with Robert Califf, Trinity '73 and School of Medicine '78, who served as Commissioner of Food and Drugs from 2016 to 2017 and again from 2022 to 2025, about the recent “Make ...

FDA chief Marty Makary just committed to me to do a full review of the chemical abortion drug’s safety: “As Commissioner of Food and Drugs, I am committed to conducting a review of ...

Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with pitfalls. Here's his tips for how to use them successfully.